Huckel Hubert E Md - Net Worth and Insider Trading
Huckel Hubert E Md Net Worth
The estimated net worth of Huckel Hubert E Md is at least $31 Million dollars as of 2024-11-10. Huckel Hubert E Md is the Director of Catalyst Pharmaceuticals Inc and owns about 1,304,134 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $31 Million. Huckel Hubert E Md is also the Director of ThermoGenesis Holdings Inc and owns about 4 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $0. Details can be seen in Huckel Hubert E Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Huckel Hubert E Md has not made any transactions after 2012-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Huckel Hubert E Md
Huckel Hubert E Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Huckel Hubert E Md owns 3 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , Titan Pharmaceuticals Inc (TTNP) , and ThermoGenesis Holdings Inc (THMO) .
Click here to see the complete history of Huckel Hubert E Md’s form 4 insider trades.
Insider Ownership Summary of Huckel Hubert E Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-24 | director & 10 percent owner |
| TTNP | Titan Pharmaceuticals Inc | 2003-10-20 | director |
| THMO | ThermoGenesis Holdings Inc | 2007-11-16 | director |
Huckel Hubert E Md Latest Holdings Summary
Huckel Hubert E Md currently owns a total of 2 stocks. Among these stocks, Huckel Hubert E Md owns 1,304,134 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 24, 2012, with a value of $31 Million and a weighting of 100%. Huckel Hubert E Md also owns 4 shares of ThermoGenesis Holdings Inc (THMO) as of November 16, 2007, with a value of $0 and a weighting of 0%.
Latest Holdings of Huckel Hubert E Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-24 | 1,304,134 | 23.93 | 31,207,927 |
| THMO | ThermoGenesis Holdings Inc | 2007-11-16 | 4 | 0.00 | 0 |
Holding Weightings of Huckel Hubert E Md
Huckel Hubert E Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Huckel Hubert E Md has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 125,000 shares on May 24, 2012, which cost Huckel Hubert E Md around $100,000.
According to the SEC Form 4 filings, Huckel Hubert E Md has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 4 shares on November 16, 2007, which cost Huckel Hubert E Md around $284,700.
Insider Trading History of Huckel Hubert E Md
- 1
Huckel Hubert E Md Trading Performance
GuruFocus tracks the stock performance after each of Huckel Hubert E Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Huckel Hubert E Md is 52.52%. GuruFocus also compares Huckel Hubert E Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Huckel Hubert E Md within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Huckel Hubert E Md's insider trading performs compared to the benchmark.
Performance of Huckel Hubert E Md
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.55 | | | | | |
| Relative Return to S&P 500(%) | 19.23 | | | | | |
Huckel Hubert E Md Ownership Network
Ownership Network List of Huckel Hubert E Md
Ownership Network Relation of Huckel Hubert E Md
Huckel Hubert E Md Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Huckel Hubert E Md is the director & 10 percent owner of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Huckel Hubert E Md made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Huckel Hubert E Md Mailing Address
Above is the net worth, insider trading, and ownership report for Huckel Hubert E Md. You might contact Huckel Hubert E Md via mailing address: C/o Titan Pharmaceuticals Inc, 400 Oyster Point Blvd, S San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
